ScholarIQanswers from OpenAlex

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)

PaperCitations, authors & open-access status

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) have?

ScholarIQcitation count

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) has 95 citations in the OpenAlex counts ScholarIQ stores.

When was Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) published?

ScholarIQyear

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) has 2017 year in the ScholarIQ index.

What is the open-access status of Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)?

ScholarIQoa status

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) has green oa status in the ScholarIQ index.

What is the DOI of Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)?

ScholarIQdoi

The DOI for Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) is on the source record.

What is the PMID of Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)?

ScholarIQpmid

The PMID for Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) is on the source record.

What is the OpenAlex record for Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)?

ScholarIQopenalex

The OpenAlex for Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial